Header image for Vitalis 2023
Profile image for Preparing Swedish Healthcare and Life Science for the Quantum Technology Era

Preparing Swedish Healthcare and Life Science for the Quantum Technology Era Passed

Tuesday May 23, 2023 14:30 - 15:00 F3

Lecturer: Ebba Carbonnier

Track: Innovation

In healthcare and life sciences, quantum technologies can play a transformative role in advancing precision health and precision medicine. Applications such as quantum microscopy, quantum spectroscopy, and quantum computing can improve disease prediction, prevention, diagnosis, and treatment. For example, quantum microscopy can enhance eye imaging, quantum spectroscopy can monitor tissue oxygenation in the heart and brain, and quantum computing can aid in understanding diseases such as Alzheimer's, Parkinson's, and ALS, as well as accelerate drug development.


In this session, we will present our eight quantum technology projects within the health and life science sector.

Language

English

Seminar type

Live broadcast

Objective of lecture

Orientation

Level of knowledge

Introductory

Target audience

Management/decision makers
Organizational development
Technicians/IT/Developers
Patient/user organizations

Keyword

Actual examples (good/bad)
Innovation/research

Conference

Vitalis

Lecturers

Profile image for Ebba Carbonnier

Ebba Carbonnier Lecturer

Portfolio Manager Swelife and Director Quantum Life Science Center
Swelife and Karolinska Institutet

Ebba Carbonnier serves as the Director of the Swedish Quantum Life Science Centre, based at the Karolinska Institute. In her role, Carbonnier leads a consortium of academics, healthcare professionals, and industry representatives from organizations such as the Wallenberg Center for Quantum Technology (WACQT), AstraZeneca, IBM, Karolinska Institute and Swelife, who work together to develop quantum technology applications for healthcare and industry.

Carbonnier also works with the strategy and management of a portfolio with national projects in healthcare and life sciences, including gene sequencing, cell- and therapies, and biobanking. Prior to her work at Karolinska Institutet, Carbonnier amassed 14 years of management consulting experience, where she created strategies, managed multidisciplinary teams and implemented large-scale multinational projects for global companies such as AstraZeneca, Microsoft, and Sandvik. Carbonnier holds an MSc and an MBA with a focus on Operations Management.